MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA

This adverse event was reported 51 times

These drugs are most commonly taken by patients reporting MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA:

# Drug Count
0 RITUXIMAB 19
1 CYCLOPHOSPHAMIDE 17
2 CYCLOPHOSPHAMIDE FOR INJECTION 17
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 17
4 GABAPENTIN 16
5 AXICABTAGENE CILOLEUCEL 14
6 CYTARABINE 14
7 ETOPOSIDE 14
8 PANTOPRAZOLE 14
9 ATOVAQUONE 13
See all common drugs associated with MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA

MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AVATROMBOPAG MALEATE 7 0.0030
1 ATOVAQUONE 13 0.0016
2 AXICABTAGENE CILOLEUCEL 14 0.0014
3 IDECABTAGENE VICLEUCEL 1 0.0008
4 IFOSFAMIDE FOR INJECTION 13 0.0006
5 AVELUMAB 2 0.0005
6 TAMSULOSIN HYDROCHLORIDE 10 0.0005
7 VINCRISTINE SULFATE 9 0.0003
8 TRIPTORELIN 1 0.0003
9 IRBESARTAN 13 0.0003
See all drugs enriched for association with MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA